Close Menu

Mass Genomics's Dan Koboldt rounds up a recent cancer genomics meeting in St. Louis, which included talks from Peter Campbell, Richard Gibbs, and Elaine Mardis, among others. Campbell introduced the Wellcome Trust Sanger Institute's first cancer genome; Gibbs spoke about Baylor's multiple-platform approach to whole genome sequencing; and Mardis gave an overview of the strategies being used at Washington University to use next-gen sequencing to study cancer genomes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.